Best Hospitals for Thalassemia Surgery in Dubai, UAE

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include bone marrow transplant rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

• Thalassaemia major (Cooley's anaemia) and thalassaemia intermedia are autosomal recessive disorders arising from mutations in the HBB gene (beta-thalassaemia) or HBA1/HBA2 genes (alpha-thalassaemia), resulting in deficient or absent globin chain synthesis.
• The consequent ineffective erythropoiesis and peripheral haemolysis produce severe microcytic anaemia (haemoglobin 2–7 g/dL untreated), obligating patients to lifelong red cell transfusions every 2–4 weeks from infancy.
• This transfusion burden generates progressive iron overload (serum ferritin often >2,500 ng/mL; liver iron concentration >7 mg Fe/g dry weight by MRI R2* quantification), leading to hepatic cirrhosis, cardiac siderosis (T2* cardiac MRI <10 ms indicating severe myocardial iron), endocrinopathies including hypogonadotropic hypogonadism, growth retardation, and hypothyroidism, as well as extramedullary haematopoiesis causing hepatosplenomegaly.

Who is a Candidate?

Treatment Options & Approaches

• STANDARD MYELOABLATIVE CONDITIONING (MAC) — GOLD STANDARD FOR CLASS I–II PATIENTS:

Recovery

• PHASE 1 — PRE-TRAVEL ASSESSMENT (Weeks -12 to -8 before transplant admission): GAF Healthcare coordinates remote case evaluation: medical records, mutation reports, HLA typing results, ferritin trends, organ function data, and existing chelation history are reviewed by the destination transplant team.
• A formal eligibility report is issued within 5–7 working days.
• Concurrently, HLA typing of all available family members is initiated or reviewed to identify the optimal donor category (MSD > MUD > Haploidentical).